Oncologic and reproductive outcomes of fertility-sparing surgery for borderline ovarian tumors: first presentation of 10-year experience from a Serbian referral center

Colombo N, Sessa C, du Bois A, Ledermann J, McCluggage WG, McNeish I, Morice P, Pignata S, Ray-Coquard I, Vergote I, Baert T, Belaroussi I, Dashora A, Olbrecht S, Planchamp F, Querleu D, on behalf of the ESMO-ESGO Ovarian Cancer Consensus Conference Working Group. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Ann Oncol. 2019:30:672-705. https://doi.org/10.1093/annonc/mdz062

Morris CR, Liu L, Rodriguez AO, Cress RD, Snipes K. Epidemiologic features of borderline ovarian tumors in California: a population-based study. Cancer Causes Control. 2013;24:665-74. https://doi.org/10.1007/s10552-013-0145-9

Skirnisdottir I, Garmo H, Wilander E, Holmberg L. Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer 2008;123:1897-901. https://doi.org/10.1002/ijc.23724

Sherman ME, Mink PJ, Curtis R, Cote TR, Brooks S, Hartge P, Devesa S. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Cancer. 2004;100:1045-52. https://doi.org/10.1002/cncr.20080

Gershenson DM. Management of borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol. 2017;41:49-59. https://doi.org/10.1016/j.bpobgyn.2016.09.012

Du Bois A, Trillsch F, Mahner S, Heitz F, Harter P. Management of borderline ovarian tumors. Ann Oncol. 2016;27(Suppl1):i20-2. https://doi.org/10.1093/annonc/mdw090

Ancraeynest E, Moerman P, Leunen K, Amant F, Neven P,Vergote I. Fertility preservation is safe for serous borderline ovarian tumors. Int J Gynecol Cancer. 2016;26:1399-406. https://doi.org/10.1097/IGC.0000000000000782

Yilmaz E, Sahin N, Koleli I, Melekoglu R, Tanrikut E, Faydali S, Karaer A, Coskun EI. Retrospective analysis of borderline ovarian tumors: outcomes at a single center. Acta Clin Croat. 2019;58:29-36. https://doi.org/10.20471/acc.2019.58.01.04

Song T, Hun Choi C, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG. Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as a treatment for borderline ovarian tumours. Hum Reprod. 2011;26:2008-14. https://doi.org/10.1093/humrep/der119

Johansen G, Dahm-Kähler P, Staf C, Flöter Rådestad A, Rodriguez-Wallberg KA. Reproductive and obstetrical outcomes with the overall survival of fertile-age women treated with fertility-sparing surgery for borderline ovarian tumors in Sweden: a prospective nationwide population-based study. Fertil Steril. 2021;115:157-63. https://doi.org/10.1016/j.fertnstert.2020.07.043

Kumari S, Kumar S, Bhatla N, Mathur S, Thulkar S, Kumar L. Oncologic and reproductive outcomes of borderline ovarian tumors in Indian population. Gynecol Oncol Rep. 2021;36:100756. https://doi.org/10.1016/j.gore.2021.100756

Swanton A, Bankhead CR, Kehoe S. Pregnancy rates after conservative treatment for borderline ovarian tumours: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2007;135:3-7. https://doi.org/10.1016/j.ejogrb.2007.05.011

Hauptmann S, Friedrich K, Redline R, Avril S. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria. Virchows Arch. 2017;470:125-42. https://doi.org/10.1007/s00428-016-2040-8

Hart WR. Borderline epithelial tumors of the ovary. Mod Pathol Off J U S Can Acad Pathol Inc. 2005;18(Suppl 2):S33-50. https://doi.org/10.1038/modpathol.3800307

Ya Qi, Min Wang, Yuwei Yang, Zhi Zeng, and Yingying Zhou. Analysis of Factors Influencing Relapse and Pregnancy in Patients with Borderline Ovarian Tumors. J Cancer. 2021;12(17):5275-85. https://doi.org/10.7150/jca.56387

Vasconcelos I, de Sousa Mendes M. Conservative surgery in ovarian borderline tumors: a meta-analysis with emphasis on recurrence risk. Eur J Cancer. 2015;51:620-31. https://doi.org/10.1016/j.ejca.2015.01.004

Canlorbe G , Lecointre L , Chauvet P, Azaïs H, Fauvet R , Uzan C. Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages. Gynecol Obstet Fertil Senol. 2020;48(3):287-303. https://doi.org/10.1016/j.gofs.2020.01.016

Niu L, Tian H, Xu Y, Cao J, Zhang X, Zhang J, Hou J, Lv W, Wang J, Xin L, Dong X, Xu T, Nan Y, Wei H, Chai X, Li N, Ni Y, Shang Y, Zhang L, Zhao Y. Recurrence characteristics and clinicopathological results of borderline ovarian tumors. BMC Womens Health. 2021;31;21(1):134. https://doi.org/10.1186/s12905-021-01263-y

Hannibal Y, Vang R, Junge J. A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence and development of ovarian serous carcinoma. Gynecol Oncol. 2017;144:174-80. https://doi.org/10.1016/j.ygyno.2016.11.007

Koskas M, Uzan C, Gouy S, Pautier P, Lhommé C, Haie-Meder C, Duvillard P, Morice P. Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma). Ann Surg Oncol. 2011;18:40-8. https://doi.org/10.1245/s10434-010-1293-8

Daraï E, Fauvet R, Uzan C, Gouy S, Duvillard P, Morice P. Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update. 2013;19(2):151-66. https://doi.org/10.1093/humupd/dms047

Uzan C, Berretta R, Rolla M, Gouy M, Fauvet R, Darai E, Duillard, Morice P. Menagement and prognosis of endometrioid borderline tumors of the ovary. Surg Oncol. 2012;21(3):178-84. https://doi.org/10.1016/j.suronc.2012.02.002

Delle Marchette M, Ceppi L, Andreano A, Bonazzi CM, Buda A, Grassi T, Giuliani D, Sina F, Lamanna M, Bianchi T, Lissoni AA, Landoni F, Valsecchi MG, Fruscio R. Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery. Eur J Cancer. 2019;111:61-8. https://doi.org/10.1016/j.ejca.2019.01.021

Morice P, Camatte S, El Hassan J, Pautier P, Duvillard P, Castaigne D. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril. 2001;75(1):92-6. https://doi.org/10.1016/S0015-0282(00)01633-2

Kim SS. Fertility preservation for women with borderline ovarian tumors: fertility-sparing surgery. Fertil Steril. 2021;115(1):83-4. https://doi.org/10.1016/j.fertnstert.2020.09.129

Van Leeuwen FE, Klip H, Mooij TM, van de Swaluw AM, Lambalk CB, Kortman M, Laven JS, Jansen CA, Helmerhorst FM, Cohlen BJ, Willemsen WN, Smeenk JM, Simons AH, van der Veen F, Evers JL, van Dop PA, Macklon NS, Burger CW. Risk of borderline and invasive ovarian tumors after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Hum Reprod. 2011;26(12):3456-65. https://doi.org/10.1093/humrep/der322

Spaan M, van den Belt-Dusebout AW, Lambalk CB, van Boven HH, Schats R, Kortman M, Broekmans FJM, Laven JSE, van Santbrink EJP, Braat DDM, van der Westerlaken LAJ, Cohlen BJ, Cantineau AEP, Smeenk JMJ, van Rumste MM, Goddijn M, van Golde RJT, Meeuwissen PAM, Hamilton CJCM, Ouwens GM, Gerritsma MA, Schaapveld M, Burger CW, van Leeuwen FE. Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology. J Natl Cancer Inst. 2021;113(6):699-709. https://doi.org/10.1093/jnci/djaa163

Fortin A, Hazout A, Thoury A, Alvès K, Bats AS, Dhainaut C, Madelenat P. Assisted reproductive technologies after conservative management of borderline or invasive ovarian tumors. Gynecol Obstet Fertil. 2005;33(7-8):488-97. https://doi.org/10.1016/j.gyobfe.2005.06.010

Cusido M, Fabregas R, Pere BS, Escayola C, Barri PN. Ovulation induction treatment and risk of borderline ovarian tumors. Gynecol Endocrinol. 2007;23(7):373-6. https://doi.org/10.1080/09513590701350341

Palomba S, Zupi E, Russo T, Falbo A, Del Negro S, Manguso F, Marconi D, Tolino A, Zullo F. Comparison of two fertility-sparing approaches for bilateral borderline ovarian tumours: a randomized controlled study. Hum Reprod. 2007;22:578-85. https://doi.org/10.1093/humrep/del381

Palomba S, Falbo A, Del Negro S, Rocca M, Russo T, Cariati F, Annunziata G, Tolino A, Tagliaferri P, Zullo F. Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-up. Hum Reprod. 2010;25:1966-72. https://doi.org/10.1093/humrep/deq159

Bourdel N, Huchon C, Abdel Wahab C, Azaïs H, Bendifallah S, Bolze PA, Brun JL, Canlorbe G, Chauvet P, Chereau E, Courbiere B, De La Motte Rouge T, Devouassoux-Shisheboran M, Eymerit-Morin C, Fauvet R, Gauroy E, Gauthier T, Grynberg M, Koskas M, Larouzee E, Lecointre L, Levêque J, Margueritte F, Mathieu D'argent E, Nyangoh-Timoh K, Ouldamer L, Raad J, Raimond E, Ramanah R, Rolland L, Rousset P, Rousset-Jablonski C, Thomassin-Naggara I, Uzan C, Zilliox M, Daraï E. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF). Eur J Obstet Gynecol Reprod Biol. 2021;256:492-501. https://doi.org/10.1016/j.ejogrb.2020.11.045

留言 (0)

沒有登入
gif